Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 10 | 75 | 1,160 | 10,163 |
| Gross Profit | N/A | 10 | 75 | 1,160 | 10,163 |
| Operating Expenses | 40,039 | 39,285 | 47,478 | 64,607 | 61,672 |
| Operating Income | -40,039 | -39,275 | -47,403 | -63,447 | -51,509 |
| Other Income | 2,160 | 2,376 | 715 | 20 | 483 |
| Pre-tax Income | -37,879 | -36,899 | -46,689 | -63,427 | -51,027 |
| Net Income Continuous | -37,879 | -36,899 | -46,689 | -63,427 | -51,027 |
| Net Income | $-37,879 | $-36,899 | $-46,689 | $-63,427 | $-51,027 |
| EPS Basic Total Ops | -59.00 | -58.00 | -89.00 | -123.00 | -112.00 |
| EPS Basic Continuous Ops | -58.75 | -58.25 | -88.88 | -123.27 | -111.61 |
| EPS Diluted Total Ops | -59.00 | -58.00 | -89.00 | -123.00 | -112.00 |
| EPS Diluted Continuous Ops | -58.75 | -58.25 | -88.88 | -123.27 | -111.61 |
| EPS Diluted Before Non-Recurring Items | -49.00 | -58.00 | -89.00 | -123.00 | -112.00 |
| EBITDA(a) | $-40,004 | $-39,122 | $-47,196 | $-63,183 | $-51,239 |